Omid Farokhzad
Tracked across 5 events · 37 articles · First seen May 29, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Omid Farokhzad, M.D., who is the Chair and CEO of Seer, submitted an unsolicited, non-binding proposal to acquire all outstanding shares of Seer's Class A common stock.
Jul 02, 2026 · 6 articles
Business
Impact: Farokhzad is Seer's co-founder, CEO, and chair, and one of the directors targeted for removal by Radoff and Torok. He is critical to Seer's scientific and strategic direction.
Jul 08, 2026 · 13 articles
Business
Impact: Omid Farokhzad, Chair and CEO of Seer, Inc., emphasized the company's commitment to protecting its technology and innovations through legal action.
May 29, 2026 · 6 articles
Business
Seer, Inc. (Nasdaq: SEER), a proteomics company, announced a planned transition in its Chief Financial Officer role. David Horn, who has served as President, Chief Financial Officer and Treasurer since the company began trading publicly…
Impact: Farokhzad, Seer's Chair and CEO, announced and endorsed the CFO transition, praising Horn's contributions and expressing confidence in Endweiss's ability to support the company's long-term success.
Sep 21, 2026 · 6 articles
Business
Impact: Omid Farokhzad, Chair and CEO of Seer, Inc., commented on the significance of the patent decisions, emphasizing Seer, Inc.'s commitment to defending its intellectual property.
Jul 01, 2026 · 6 articles
Seer, Inc.
ceo and bidder
↔
Omid Farokhzad
Omid Farokhzad is the current Chair and Chief Executive Officer of Seer, Inc. He
ERGEN INTELLIGENCE
Track Omid Farokhzad live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard